None listed
Conditions
Brief summary
Introduction Unstable functional re-entrant circuits known as rotors have been consistently observed in atrial fibrillation, and are mechanistically believed critical to the maintenance of the arrhythmia. Recently, using a Poisson renewal theory-based quantitative framework, we have demonstrated that rotor formation (lambda-f) and destruction rates (lambda-d) can be accurately measured using in vivo electrophysiologic data. RENEWAL-AF measures the electrical, structural heart changes associated with differences in lambda-d and lambda-f.
Interventions
RENEWAL AF is a prospective cross-sectional study at a tertiary hospital recruiting adult patients with paroxysmal or persistent atrial fibrillation (AF) undergoing clinically indicated catheter ablation. Patients will undergo intraprocedural electrophysiologic AF mapping, with lambda-f and lambda-d to be determined from 2-minute unipolar electrogram recordings acquired prior to ablation. The total duration of observation will be in a single AF EEP study procedure (usual duration 120 minutes). The primary objective will be to determine the association of lambda-f and lambda-d with clinical, electrical and structural markers of atrial fibrillation progression, measured by pre-ablation echocardiogram and cardiac magnetic resonance imaging (MRI). The secondary objective will be the association between lambda-f/lambda-d with sympathetic and cholinergic modulation using isoproterenol and edrophonium during AF ablation.
Sponsors
Eligibility
Inclusion criteria
The inclusion criteria will be patients referred for clinically indicated AF ablation at Flinders Medical Centre and any other participating sites. Clinical indication for AF ablation includes 1) symptomatic AF refractory or intolerant to at least one class 1 or class 3 antiarrhythmic medication 2) selected symptomatic patients with heart failure and/or reduced ejection fraction.
Exclusion criteria
Exclusion criteria includes 1) patients unwilling to provide consent 2) patients unable to undergo pre-procedural cardiac magnetic resonance imaging (CMRI) 3) presence of LA thrombus 4) LA diameter>5.5 cm 5) >2 previous ablations for AF 6) contraindications to anticoagulation therapy 7) uncontrolled hypertension 8) uncontrolled thyroid disease and 9) severe cardiac valvular disease.